Parabilis Medicines Shares Rocket Following Record Biotech IPO - Stock Watch Index

Parabilis Medicines Shares Rocket Following Record Biotech IPO

June 10, 2026

Oncology-focused drug company nabs $670 million in scorching stock-market debut.

Search

RECENT PRESS RELEASES

Bryant Bank Investment Helps UAH Prepare North Alabama’s Next Generation Of Nurses

SWI Editorial Staff2026-06-11T04:00:30-07:00June 11, 2026|

Eskom launches new unit to deliver South Africa’s renewables targets

SWI Editorial Staff2026-06-11T04:00:16-07:00June 11, 2026|

Oracle’s data center spending worries investors

SWI Editorial Staff2026-06-11T04:00:05-07:00June 11, 2026|

Six Credibility Signals That Separate Real Advisors From Noise

SWI Editorial Staff2026-06-11T04:00:00-07:00June 11, 2026|

Stocks.News Adds Benzinga’s “Why Is It Moving” Feed for Real-Time Stock Market Insights

SWI Editorial Staff2026-06-11T04:00:00-07:00June 11, 2026|

Firgun Ventures Announces First Australian Investment in Silicon Quantum Computing

SWI Editorial Staff2026-06-11T03:53:53-07:00June 11, 2026|

Related Post